Literature DB >> 9039535

Parvovirus B19 diagnosis in pregnant women--quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum.

K Searle1, C Guilliard, G Enders.   

Abstract

On the basis of the results of a collaborative study the Expert Committee on Biological Standardisation of the World Health Organisation has issued an international standard (IS) serum for parvovirus B19 IgG antibody (NIBSC 93/724). In this study this IS was used to calibrate an in-house standard serum for reporting the results of parvovirus B19 IgG testing in IU/ml. The IgG titre distribution in 939 pregnant women was determined. These samples were sent to the laboratory for determining the immune status to parvovirus B19 following contact with parvovirus B19 infected individuals or for detecting acute infection in patients with symptoms suggestive of parvovirus B19 infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039535     DOI: 10.1007/BF02113504

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   7.455


  4 in total

1.  Report of a collaborative study to establish the international standard for parvovirus B19 serum IgG.

Authors:  M Ferguson; D Walker; B Cohen
Journal:  Biologicals       Date:  1997-09       Impact factor: 1.856

Review 2.  Parvovirus B19: an expanding spectrum of disease.

Authors:  B Cohen
Journal:  BMJ       Date:  1995-12-09

3.  Candidate recombinant vaccine for human B19 parvovirus.

Authors:  G P Bansal; J A Hatfield; F E Dunn; A A Kramer; F Brady; C H Riggin; M S Collett; K Yoshimoto; S Kajigaya; N S Young
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

4.  Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease.

Authors: 
Journal:  BMJ       Date:  1990-05-05
  4 in total
  5 in total

1.  Impaired gamma interferon responses against parvovirus B19 by recently infected children.

Authors:  A Corcoran; S Doyle; D Waldron; A Nicholson; B P Mahon
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany.

Authors:  M Enders; A Weidner; G Enders
Journal:  Epidemiol Infect       Date:  2006-10-26       Impact factor: 2.451

3.  Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans.

Authors:  Oscar Norbeck; Adiba Isa; Christoph Pöhlmann; Kristina Broliden; Victoria Kasprowicz; Paul Bowness; Paul Klenerman; Thomas Tolfvenstam
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Long term follow up of serostatus after maternofetal parvovirus B19 infection.

Authors:  J Dembinski; A M Eis-Hübinger; J Maar; R Schild; P Bartmann
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

5.  Acute parvovirus B19 infection in pregnant women--an analysis of serial samples by serological and semi-quantitative PCR techniques.

Authors:  K Searle; C Guilliard; S Wallat; G Schalasta; G Enders
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 7.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.